Edwards Lifesciences (EW) Shares Outstanding (2009 - 2026)

Edwards Lifesciences' Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $660.0 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 0.63% year-over-year to $660.0 million in Q1 2026; TTM through Mar 2026 was $660.0 million, a 0.63% increase from a year earlier, with the FY2025 full-year figure at $658.7 million, up 0.6% from the prior year.
• Shares Outstanding (Entity) held at $660.0 million in Q1 2026 per EW's latest filing, from $658.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $660.0 million in Q1 2026 and bottomed at $642.9 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $651.8 million (2024), against an average of $651.8 million.
• Across the five-year window, Shares Outstanding (Entity) rose 0.85% in 2022 and rose 0.6% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $646.3 million in 2022, then advanced by 0.65% to $650.5 million in 2023, then rose by 0.66% to $654.8 million in 2024, then grew by 0.6% to $658.7 million in 2025, then advanced by 0.2% to $660.0 million in 2026.
• Per Business Quant, the three latest EW Shares Outstanding (Entity) figures stand at $660.0 million (Q1 2026), $658.7 million (Q4 2025), and $658.2 million (Q3 2025).